DOI:
10.1055/s-00000022
Das Gesundheitswesen
LinksClose Window
References
Kondo M, Hoshi S-l, Yamanaka T et al.
Economic evaluation of the 21-gene signature (Oncotype DX®) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03).
Breast Cancer Res Treat 2011;
127: 739-749
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.